SEC Form 3 · accession 0001140361-26-029805
Freenome, Inc. · FRNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cheng-Ho Jimmy Lin
Officer — Chief Scientific Officer
Period of report
Jul 20, 2026
Accepted (ET)
Jul 27, 2026 · 8:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002017526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 410,154 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.85 | holding | — | — | — | — | Jul 30, 2029 | Common Stock | 10,849 | — | D |
| Stock Option (right to buy)F1 | $4.85 | holding | — | — | — | — | Oct 15, 2029 | Common Stock | 145,561 | — | D |
| Stock Option (right to buy)F5,F1 | $15.91 | holding | — | — | — | — | Jun 21, 2032 | Common Stock | 140,685 | — | D |
| Stock Option (right to buy)F5,F2 | $11.88 | holding | — | — | — | — | Feb 17, 2033 | Common Stock | 49,651 | — | D |
| Stock Option (right to buy)F5,F3 | $18.24 | holding | — | — | — | — | Feb 15, 2034 | Common Stock | 78,331 | — | D |
| Stock Option (right to buy)F5,F4 | $14.00 | holding | — | — | — | — | Mar 10, 2035 | Common Stock | 150,019 | — | D |
Explanation of responses
- F1The shares subject to this option are fully vested.
- F225% of the shares subject to this option shall vest and become exercisable on February 2, 2024 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F3The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from February 16, 2024, subject to the Reporting Person's continued service on each such vesting date.
- F425% of the shares subject to this option shall vest and become exercisable on February 15, 2026 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
- F5This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.
Remarks
Exhibit 24 - Power of Attorney